MMP9 and hydrops fetalis: In an in vitro TGFβ-induced cardiac fibroblast model, calycosin exhibits anti-fibrotic activity at a dose of 5 μM by decreasing α-smooth muscle actin (α-SMA) expression and reducing p-STAT3 and matrix metalloproteinase-9 (MMP-9) levels against HF [34,35].